Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose testosterone gel detection study in healthy women
ACTRN12619000633189Phase 4Completed
- Sponsor
- Sydney Local Health District
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of testosterone, sponsored by Sydney Local Health District. Primary endpoints: Exploratory urine steroid profile including carbon isotope ratio of testosterone and its 5alpha-reduced metabolites and Exploratory blood steroid profile including serum testosterone. Started May 2019; status: completed.
02
Drugs
testosterone
Beyond the preview
Go deeper on ACTRN12619000633189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000633189.